vs
Side-by-side financial comparison of DELUXE CORP (DLX) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
DELUXE CORP is the larger business by last-quarter revenue ($535.2M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.2%, a 4.6% gap on every dollar of revenue. On growth, DELUXE CORP posted the faster year-over-year revenue change (2.8% vs -1.7%). Over the past eight quarters, DELUXE CORP's revenue compounded faster (0.0% CAGR vs -0.1%).
Deluxe Corporation is an American company that provides payment processing, data services, checks and promotional products, and merchant services. It operates in four divisions: B2B payments, data, print, and merchant services. As of 2025, the company serves millions of small businesses and thousands of financial institutions, processing more than $2.8 trillion in payments annually. While its legacy business centers on check printing and other printed products, payments and data services now ...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DLX vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $535.2M | $493.8M |
| Net Profit | $12.0M | $33.7M |
| Gross Margin | 52.2% | — |
| Operating Margin | 8.9% | 9.9% |
| Net Margin | 2.2% | 6.8% |
| Revenue YoY | 2.8% | -1.7% |
| Net Profit YoY | -5.0% | 10.5% |
| EPS (diluted) | $0.25 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $535.2M | $493.8M | ||
| Q3 25 | $540.2M | $492.9M | ||
| Q2 25 | $521.3M | $468.8M | ||
| Q1 25 | $536.5M | $458.4M | ||
| Q4 24 | $520.6M | $502.4M | ||
| Q3 24 | $528.4M | $511.2M | ||
| Q2 24 | $537.8M | $504.3M | ||
| Q1 24 | $535.0M | $495.1M |
| Q4 25 | $12.0M | $33.7M | ||
| Q3 25 | $33.7M | $71.7M | ||
| Q2 25 | $22.4M | $39.3M | ||
| Q1 25 | $14.0M | $20.7M | ||
| Q4 24 | $12.6M | $30.5M | ||
| Q3 24 | $8.9M | $19.4M | ||
| Q2 24 | $20.5M | $-153.0M | ||
| Q1 24 | $10.8M | $4.0M |
| Q4 25 | 52.2% | — | ||
| Q3 25 | 53.9% | — | ||
| Q2 25 | 53.6% | — | ||
| Q1 25 | 52.4% | — | ||
| Q4 24 | 52.3% | — | ||
| Q3 24 | 53.3% | — | ||
| Q2 24 | 53.7% | — | ||
| Q1 24 | 53.0% | — |
| Q4 25 | 8.9% | 9.9% | ||
| Q3 25 | 14.0% | 13.8% | ||
| Q2 25 | 11.7% | 12.8% | ||
| Q1 25 | 9.0% | 7.0% | ||
| Q4 24 | 9.0% | 7.8% | ||
| Q3 24 | 7.9% | 6.6% | ||
| Q2 24 | 11.0% | -31.3% | ||
| Q1 24 | 8.3% | 3.2% |
| Q4 25 | 2.2% | 6.8% | ||
| Q3 25 | 6.2% | 14.5% | ||
| Q2 25 | 4.3% | 8.4% | ||
| Q1 25 | 2.6% | 4.5% | ||
| Q4 24 | 2.4% | 6.1% | ||
| Q3 24 | 1.7% | 3.8% | ||
| Q2 24 | 3.8% | -30.3% | ||
| Q1 24 | 2.0% | 0.8% |
| Q4 25 | $0.25 | $0.40 | ||
| Q3 25 | $0.74 | $0.84 | ||
| Q2 25 | $0.50 | $0.46 | ||
| Q1 25 | $0.31 | $0.24 | ||
| Q4 24 | $0.28 | $0.37 | ||
| Q3 24 | $0.20 | $0.23 | ||
| Q2 24 | $0.46 | $-1.84 | ||
| Q1 24 | $0.24 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.9M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $680.7M | $865.9M |
| Total Assets | $2.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.9M | $375.2M | ||
| Q3 25 | $25.8M | $340.1M | ||
| Q2 25 | $26.0M | $224.7M | ||
| Q1 25 | $30.3M | $99.0M | ||
| Q4 24 | $34.4M | $229.9M | ||
| Q3 24 | $41.3M | $103.8M | ||
| Q2 24 | $23.1M | $19.4M | ||
| Q1 24 | $23.5M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $680.7M | $865.9M | ||
| Q3 25 | $664.1M | $890.7M | ||
| Q2 25 | $638.7M | $833.8M | ||
| Q1 25 | $622.5M | $789.2M | ||
| Q4 24 | $620.9M | $764.9M | ||
| Q3 24 | $612.7M | $732.5M | ||
| Q2 24 | $620.5M | $706.5M | ||
| Q1 24 | $608.4M | $856.2M |
| Q4 25 | $2.9B | $2.2B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.8B | $2.2B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.7B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $102.1M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 8.53× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $102.1M | $114.1M | ||
| Q3 25 | $67.1M | $137.3M | ||
| Q2 25 | $51.1M | $137.2M | ||
| Q1 25 | $50.3M | $-117.5M | ||
| Q4 24 | $60.2M | $133.0M | ||
| Q3 24 | $67.9M | $91.8M | ||
| Q2 24 | $39.6M | $107.0M | ||
| Q1 24 | $26.6M | $-125.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $27.8M | — | ||
| Q1 25 | $24.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $46.7M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $6.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 3.8% | — |
| Q4 25 | 8.53× | 3.39× | ||
| Q3 25 | 1.99× | 1.91× | ||
| Q2 25 | 2.28× | 3.49× | ||
| Q1 25 | 3.59× | -5.66× | ||
| Q4 24 | 4.77× | 4.36× | ||
| Q3 24 | 7.60× | 4.72× | ||
| Q2 24 | 1.94× | — | ||
| Q1 24 | 2.46× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLX
| Services | $247.9M | 46% |
| B2B Payments | $76.3M | 14% |
| Datadrivenmarketingsolutions | $68.5M | 13% |
| Promotional Solutions Revenue | $60.9M | 11% |
| Treasurymanagementsolutions | $59.8M | 11% |
| Other | $17.3M | 3% |
| Other Web Based Solutions | $4.6M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
